Citation Impact
Citing Papers
Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders
2000
Dopamine Receptors and Dopamine Transporter in Brain Function and Addictive Behaviors: Insights from Targeted Mouse Mutants
1998
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes
1990
Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors
1991
Thalamocortical Oscillations in the Sleeping and Aroused Brain
1993 StandoutScience
Effects of the substituted (S)-3-phenylpiperidine (−)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains
1999 StandoutNobel
Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein in mice
2006
Glutamatergic control over brain dopamine release in vivo and in vitro
1997
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
Seeing (and Using) the Light: Recent Developments in Bioluminescence Technology
2020
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway
2000 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431
1996
Dopamine D1 Agonist SKF 38393 Increases the State of Phosphorylation of ARPP‐21 in Substantia Nigra
1993 StandoutNobel
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
1992
Narcolepsy in orexin Knockout Mice
1999 Standout
Extensive co‐occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization
1990
The relationship between unmyelinated afferent type and neurogenic plasma extravasation in normal and reinnervated rat skin
1992
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
1994
Direct evidence for the stimulation of rabbit retina dopamine receptors by ergot alkaloids
1976
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Behavioral arrest: in search of the neural control system
2001
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant
1992
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
1988
Regional (14C) 2‐deoxyglucose uptake during forelimb movements evoked by rat motor cortex stimulation: Cortex, diencephalon, midbrain
1984
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Alzheimer's Disease
2004 Standout
The Tachykinin Peptide Family
2002
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
EFFECTS OF MODULATORS OF ARACHIDONIC ACID METABOLISM ON THE SYNTHESIS AND RELEASE OF SLOW‐REACTING SUBSTANCE OF ANAPHYLAXIS
1979
Immunocytochemistry with internally labeled monoclonal antibodies.
1982 StandoutNobel
Müller cell localisation of glutamine synthetase in rat retina
1977 Nature
Biochemical evidence for γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat
1980
The thalamus as a neuronal oscillator
1984
A pharmacological analysis of aspirin.
1969
Baclofen and muscimol: Behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding
1979
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
1990 StandoutScience
Aquaporin-4 Water Channel Protein in the Rat Retina and Optic Nerve: Polarized Expression in Müller Cells and Fibrous Astrocytes
1998 StandoutNobel
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989 StandoutNobel
The tachykinin peptide family
1981
ALCOHOL-STIMULATED CALCITONIN RELEASE IN MEDULLARY CARCINOMA OF THE THYROID
1973
Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons
1985
Calcitonin gene-related peptide is a potent vasodilator
1985 StandoutNature
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
G Protein Activation by Human Dopamine D3 Receptors in High-Expressing Chinese Hamster Ovary Cells: A Guanosine-5′-O-(3-[35S]thio)-Triphosphate Binding and Antibody Study
1999
3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain
1981 StandoutNature
Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography
1983
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
1990 StandoutScience
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium
1983 StandoutNature
Modulation of Both the Early and the Late Phase of Mossy Fiber LTP by the Activation of β-Adrenergic Receptors
1996 StandoutNobel
Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α-, β-, and γ-preprotachykinin
1989 StandoutNobel
Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals
1978
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis
1984
Multiple receptors for dopamine
1979 StandoutNature
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
1980 StandoutNatureNobel
Altered striatal function in a mutant mouse lacking D1A dopamine receptors.
1994
The Intrinsic Electrophysiological Properties of Mammalian Neurons: Insights into Central Nervous System Function
1988 StandoutScience
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist
1981
Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems
1990
Transformation of retinal glia cells into lens phenotype: expression of MP26, a lens plasma membrane antigen.
1983 StandoutNobel
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
1990 StandoutScience
Induction of glutamine synthetase in embryonic neural retina: localization in Müller fibers and dependence on cell interactions.
1979
THE EFFECT OF ANTI‐INFLAMMATORY DRUGS ON VASCULAR SMOOTH MUSCLE
1967
Substance P as a Transmitter Candidate
1980
Substance P in the human brain
1986
Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)
1972 StandoutNatureNobel
Extracellular K+ activity changes related to electroretinogram components. II. Rabbit (E-type) retinas.
1985
Amino acid transmitters in the mammalian central nervous system
1974
Role of stimulation of arachidonic acid release in the proliferative response of 3T3 mouse fibroblasts to platelet‐derived growth factor
1982
Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan
2012
Release of renal prostaglandins during endotoxin-induced hypotension
1976 StandoutNobel
Detection of substance P in the central nervous system by a monoclonal antibody.
1979 StandoutNobel
Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions
1987
(–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
1980 Nature
A new approach to anti-inflammatory drugs
1979 StandoutNobel
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype
2011 StandoutNobel
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
A polymorphic DNA marker genetically linked to Huntington's disease
1983 StandoutNature
Neurotransmitters in Huntington's Chorea—a Clinician's View
1982
Both Protein Kinase A and Mitogen-Activated Protein Kinase Are Required in the Amygdala for the Macromolecular Synthesis-Dependent Late Phase of Long-Term Potentiation
2000 StandoutNobel
Expression of c- fos Protein in Brain: Metabolic Mapping at the Cellular Level
1988 StandoutScience
Works of Michael S. Starr being referenced
Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic l-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat
1998
Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist
1995
Antiparkinsonian actions of glutamate antagonists — alone and with L-DOPA: A review of evidence and suggestions for possible mechanisms
1995
The role of dopamine in epilepsy
1996
Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain
2000
Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat
1989
Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours
1987
Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease
1995
Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat
1990
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801
1992
Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse
1990
Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors
1995
Facilitation of dopamine D1 receptor- but not dopamine receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse
1993
Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors
1990
Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse
1995
Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine
1993
D-1 / D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors
1988
Stimulation of basal and l-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease
1997
Motor depression: A new role for D1 receptors?
1990
NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats
1996
BRADYKININ AND OEDEMA FORMATION IN HEATED PAWS OF RATS
1967
The uptake, metabolism and release of14C-taurine by rat retina in vitro
1972
Opposing Roles of Dopamine D1 and D2 Receptors in Nigral γ‐[3H]Aminobutyric Acid Release?
1987
POTENTIATION BY SUBSTANCE P OF CONTRACTIONS OF THE ISOLATED VAS DEFERENS OF THE MOUSE ELICITED BY ELECTRIC FIELD STIMULATION AND BY DRUGS
1978
Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat
1977
Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion
1987
Evidence for a GABAergic nigrothalamic pathway in the rat
1980
Specificity of GABA as a stimulator of dopamine release in rat substantia nigra
1980
Role of the ventromedial nucleus of the thalamus in motor behaviour—I. Effects of focal injections of drugs
1983
Evidence for a GABAergic nigrothalamic pathway in the rat
1980
Role of the ventromedial nucleus of the thalamus in motor behaviour—II. Effects of lesions
1983
GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro
1979
Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus
1984
Bilateral asymmetry in brain GABA function?
1981
Effect of amino-oxyacetic acid on the accumulation of 3H- -aminobutyric acid (3H-GABA) by rat retina.
1973
The effect of bradykinin and anti-inflammatory agents on isolated arteries
1966
Effect of inhibitors of γ‐aminobutyrate aminotransferase on the accumulation of H‐γ‐aminobutyric acid by the retina
1973
Behavioural depressant and antinociceptive properties of substance P in the mouse: Possible implication of brain monoamines
1978
Influence of peptides on 3H-dopamine release from superfused rat striatal slices
1982
GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum
1978
PHARMACOLOGICAL BLOCKADE OF CARCINOID FLUSHING PROVOKED BY CATECHOLAMINES AND ALCOHOL
1969
Investigation of possible interactions between substance P and transmitter mechanisms in the substantia nigra and corpus striatum of the rat
1978
EFFECTS OF SUBSTANCE P INJECTED INTO THE SUBSTANTIA NIGRA
1979
Distribution of γ-aminobutyrate in the rat thalamus: Specific decreases in thalamic γ-aminobutyrate following lesion or electrical stimulation of the substantia nigra
1981
The efflux of radioactive GABA from rat retina in vitro
1972
The role of GABA in the substantia nigra
1978 Nature
Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat
1982
ÈVIDENCE FOR THE COMPARTMENTATION OF GLUTAMATE METABOLISM IN ISOLATED RAT RETINA
1974
The effects of various amino acids, dopamine and some convulsants on the electroretinogram of the rabbit
1975
The uptake of [14C]γ-aminobutyric acid by the isolated retina of the rat
1972
Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse
1986
Evidence for the participation of nigrotectal γ-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat
1982